|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1840282320 |
| 003 |
DE-627 |
| 005 |
20230404081719.0 |
| 007 |
tu |
| 008 |
230328s2022 gw ||||| m 00| ||eng c |
| 035 |
|
|
|a (DE-627)1840282320
|
| 035 |
|
|
|a (DE-599)KXP1840282320
|
| 035 |
|
|
|a (OCoLC)1374083622
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-DE-BW
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 100 |
1 |
|
|a Lin, Min
|d 1992-
|e VerfasserIn
|0 (DE-588)1284581004
|0 (DE-627)1840280670
|4 aut
|
| 245 |
1 |
0 |
|a Optimizations of anti-tumor efficacy during CD19-specific chimeric antigen receptor (CAR) T/NK-cell manufacturing
|c vorgelegt von Min Lin ; Doktorvater: Herr Prof. Dr. med. Michael Schmitt
|
| 246 |
3 |
3 |
|a Optimizations of anti-tumor efficacy during CD nineteen -specific chimeric antigen receptor (CAR) T/NK-cell manufacturing
|
| 264 |
|
1 |
|a Heidelberg
|c 2022
|
| 300 |
|
|
|a 89 Blätter
|b Illustrationen, Diagramme
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Zusammenfassung in deutscher und englischer Sprache
|
| 502 |
|
|
|b Dissertation
|c Ruprecht-Karls-Universität Heidelberg
|d 2022
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 700 |
1 |
|
|a Schmitt, Michael
|d 1966-
|e AkademischeR BetreuerIn
|0 (DE-588)133177173
|0 (DE-627)538000600
|0 (DE-576)299672921
|4 dgs
|
| 710 |
2 |
|
|a Universität Heidelberg
|e Grad-verleihende Institution
|0 (DE-588)2024349-2
|0 (DE-627)102161488
|0 (DE-576)191769517
|4 dgg
|
| 751 |
|
|
|a Heidelberg
|0 (DE-588)4023996-2
|0 (DE-627)106300814
|0 (DE-576)208952578
|4 uvp
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20230405
|
| 993 |
|
|
|a Thesis
|
| 994 |
|
|
|a 2022
|
| 998 |
|
|
|g 1284581004
|a Lin, Min
|m 1284581004:Lin, Min
|d 50000
|d 51001
|e 50000PL1284581004
|e 51001PL1284581004
|k 0/50000/
|k 1/50000/51001/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1840282320
|e 4303011258
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"language":["eng"],"type":{"bibl":"thesis"},"note":["Zusammenfassung in deutscher und englischer Sprache"],"title":[{"title_sort":"Optimizations of anti-tumor efficacy during CD19-specific chimeric antigen receptor (CAR) T/NK-cell manufacturing","title":"Optimizations of anti-tumor efficacy during CD19-specific chimeric antigen receptor (CAR) T/NK-cell manufacturing"}],"origin":[{"dateIssuedDisp":"2022","dateIssuedKey":"2022","publisherPlace":"Heidelberg"}],"person":[{"given":"Min","role":"aut","family":"Lin","display":"Lin, Min"},{"family":"Schmitt","given":"Michael","role":"dgs","display":"Schmitt, Michael"}],"physDesc":[{"noteIll":"Illustrationen, Diagramme","extent":"89 Blätter"}],"noteThesis":["Dissertation. - Ruprecht-Karls-Universität Heidelberg. - 2022"],"recId":"1840282320","id":{"eki":["1840282320"]},"corporate":[{"display":"Universität Heidelberg","role":"dgg"}],"name":{"displayForm":["vorgelegt von Min Lin ; Doktorvater: Herr Prof. Dr. med. Michael Schmitt"]},"titleAlt":[{"title":"Optimizations of anti-tumor efficacy during CD nineteen -specific chimeric antigen receptor (CAR) T/NK-cell manufacturing"}]}
|
| SRT |
|
|
|a LINMINOPTIMIZATI2022
|
